Serum anti-p53 antibody titers predict pathological response to preoperative chemotherapy in women with HER2 positive or triple negative breast cancer.

Saved in:
Bibliographic Details
Title: Serum anti-p53 antibody titers predict pathological response to preoperative chemotherapy in women with HER2 positive or triple negative breast cancer.
Authors: Yoshiyama, T.1, Nakamura, Y.1, Igawa, A.1, Saruwatari, A.1, Shigechi, T.1, Ueda, N.1, Kuba, S.1, Ishida, M.1, Nishimura, S.1, Nishiyama, K.1, Ohno, S.1
Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p921-921. 1p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first